Speaking of Science

January 2015's selection of notable quotes

Jan 1, 2015
The Scientist Staff

© ISTOCKPHOTO.COM/ABLUECUPWe know researchers are already sharing content, often in hidden corners of the Internet or using clumsy, time-consuming practices.

Timo Hannay, managing director of Digital Science, which is owned by Macmillan Publishers, in a statement announcing a move by the publisher to make the contents of all journals under Nature Publishing Group freely readable online to users sent a link to a paper by a subscriber (December 2)


To me, this smacks of public relations, not open access. With access mandates on the march around the world, this appears to be more about getting ahead of the coming reality in scientific publishing. Now that the funders call the tune and the funders want the articles on the web at no charge, these articles are going to be open anyway.

—Open-access advocate and senior fellow at the Ewing Marion Kauffman Foundation in Kansas City, Missouri, John Wilbanks, in a comment about the announcement of the new Macmillan Publishers policy that all Nature Publishing Group journals will be free to read online if subscribers share a link (Nature News, December 2)


The development of full artificial intelligence could spell the end of the human race. Once humans develop artificial intelligence, it would take off on its own and redesign itself at an ever increasing rate. Humans, who are limited by slow biological evolution, couldn’t compete and would be superseded.

—University of Cambridge theoretical physicist Stephen Hawking, talking to the BBC about the dangers of developing artificial intelligence (December 2)


We are drowning in information, while starving for wisdom. The world henceforth will be run by synthesizers, people able to put together the right information at the right time, think critically about it, and make important choices wisely. 

—Harvard biologist E.O. Wilson, in his 1998 book Consilience: The Unity of Knowledge


Because I was an “unperson” I was fired from the boards of companies, so I have no income, apart from my academic income.

James Watson, Chancellor Emeritus of Cold Spring Harbor Laboratory, and codiscoverer of the double-helical structure of DNA, describing his partial motivation for auctioning off his 1962 Nobel Prize medal, which sold on December 4 for $4.1 million (Financial Times, November 28)


In my opinion, a situation in which an outstanding scientist has to sell a medal recognizing his achievements is unacceptable. James Watson is one of the greatest biologists in the history of mankind, and his award for the discovery of DNA structure must belong to him.

—Russian entrepreneur Alisher Usmanov, speaking to The New York Times about his decision to return James Watson’s 1962 Nobel Prize medal after paying more than $4.1 million for it at auction (December 9)


The idea that stress plays a role in illness is becoming more and more well defined. It happens both directly and indirectly, directly through mechanisms that we partially understand but not fully, and indirectly through changes in behavior. 

Dean Ornish, University of California, San Francisco, professor of medicine and founder of the university’s Preventive Medicine Research Institute, describing science’s emerging understanding of the physiological impacts of emotional stress (December 2008)

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb


Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.